Clinical Trials Logo

Disorders clinical trials

View clinical trials related to Disorders.

Filter by:
  • None
  • Page 1

NCT ID: NCT02199704 Completed - Schizophrenia Clinical Trials

Self Directed Positive Parenting Program (Triple P) for Psychosis: A Clinical Case Series

Start date: June 2014
Phase: N/A
Study type: Interventional

The aim of the case series study is to explore if a self directed version of the Positive Parenting Program (Triple P) is a feasible and acceptable intervention for individuals with psychosis who are parents.

NCT ID: NCT01968161 Not yet recruiting - Clinical trials for Schizophrenia and Disorders With Psychotic Features

Investigator Initiated Study - Asenapine Early Psychosis

Start date: October 2013
Phase: Phase 4
Study type: Interventional

We propose a use of a unique facility, the databank at the CNDV, to examine the impact of switching subjects to asenapine in an open-label naturalistic setting. This offers the following advantages: i) providing data on a particularly important population, i.e., subjects who are at the inception of treatment for a psychotic disorder and who are likely to remain on a given drug on a long-term basis; ii) its inclusion in a rich clinical setting, with a clinical team dedicated to provide innovative interventions; iii) its naturalistic design, that will allow to obtain data that will be applicable to "real-life" clinical settings; indeed, subjects who will be switched to asenapine within the current project are those we would switch to this drug in our daily practice.

NCT ID: NCT01036217 Completed - Substance Abuse Clinical Trials

Screening Protocol for the Evaluation of Research Participants

Start date: May 17, 2006
Phase: N/A
Study type: Observational

Background: - The National Institute on Drug Abuse (NIDA) uses a standardized set of procedures to develop a pool of potential participants for research studies. Because some of the data collected during screening are used later for research, the screening itself is considered a study. An applicant to any NIDA study is considered a participant in NIDA screening. Objectives: - To identify, recruit, and screen participants for NIDA research protocols. Eligibility: - Individuals 18 years of age and older who are able to provide informed consent. Design: - Individuals who are eligible for screening will undergo two interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview. - The in-person interview may require up to five visits to NIDA. The in-person visit will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff. - During screening, a photograph will be taken for confirmation of identity during subsequent visits for other studies. - No clinical care will be provided as part of screening.